• Ep. 119: Phase 2 HOPE clinical trial results

  • 2024/10/27
  • 再生時間： 24 分
  • ポッドキャスト

Ep. 119: Phase 2 HOPE clinical trial results

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Moderator: Theodoros M. Mavridis (Dublin, Ireland)

    Guest: Messoud Ashina (Glostrup, Denmark)

    In this episode Theodoros M. Mavridis and Messoud Ashina delve into the findings of the Phase 2 HOPE clinical trial, which assesses the efficacy and safety of Lu AG09222, a monoclonal antibody that targets the PACAP pathway. They explore the potential of this innovative treatment for migraine prevention while highlighting the critical role of the PACAP pathway in migraine pathophysiology.
    続きを読む 一部表示

あらすじ・解説

Moderator: Theodoros M. Mavridis (Dublin, Ireland)

Guest: Messoud Ashina (Glostrup, Denmark)

In this episode Theodoros M. Mavridis and Messoud Ashina delve into the findings of the Phase 2 HOPE clinical trial, which assesses the efficacy and safety of Lu AG09222, a monoclonal antibody that targets the PACAP pathway. They explore the potential of this innovative treatment for migraine prevention while highlighting the critical role of the PACAP pathway in migraine pathophysiology.
続きを読む 一部表示

Ep. 119: Phase 2 HOPE clinical trial resultsに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。